Patients with high lipoprotein(a) levels may benefit from taking PCSK9 inhibitors
Lipoprotein(a) is a variant of LDL (low-density lipoprotein) cholesterol, and large amounts of data have shown that higher lipoprotein(a) levels are associated with an increased risk of cardiovascular events. Atherosclerosis ...
May 21, 2018
0
10